Dysregulations and mutations within the BAP1 gene have been identified as drivers in many human cancers, such as uveal melanoma [26–28], mesothelioma [29], clear-cell renal cell carcinoma [30, 31], leukemia [32], and breast cancer [21]. This evidence concerns the gene BAP1 and cancer.